BBOT BRIDGEBIO ONCOLOGY THERAPEUT
2026Q2 · CUSIP 107924102 · Sector: Healthcare & Biotech
Normal
Fund flows are within the usual range
Funds that own it
65
Institutions that reported holding it to the SEC
Net decrease in holders
1
Last quarter 66 → now 65
How unusual is that
Below average
Stronger than only 25% of US stocks
What the filings say, in one paragraph
65 funds held BBOT at the end of 2026Q2, down 1 from the quarter before. Fund flows are within the usual range — nothing unusual. It sits in the Healthcare & Biotech sector.
How many funds owned it, quarter by quarter
Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.
What happened after each past buying rush
This stock has never had a buying rush
Show all the numbers (large funds, value held, options…) ▾ Collapse ▴
Of them, large funds
34
Change in large funds
+4
Total value they hold
$451M
Funds buying for the first time
16
Funds that sold out entirely
17
Price change that quarter
+3.3%
Funds holding puts (bearish)
0
Funds holding calls (bullish)
0
These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.
Email me the next update
2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.